01 9Atripla
02 3Sustiva
03 2Sustiva
04 1Truvada
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 349
2019 Revenue in Millions : 600
Growth (%) : -42
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 145
2020 Revenue in Millions : 349
Growth (%) : -58
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 0
2021 Revenue in Millions : 145
Growth (%) : -100
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2014 Revenue in Millions : -10.50%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2015 Revenue in Millions : 1,444
2014 Revenue in Millions : 1,252
Growth (%) : -13%
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2015 Revenue in Millions : 3,470
2014 Revenue in Millions : 3,134
Growth (%) : -10%
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2017 Revenue in Millions : 729
2016 Revenue in Millions : 1,065
Growth (%) : -32
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2016 Revenue in Millions : 1,065
2015 Revenue in Millions : 1,252
Growth (%) : -15
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2018 Revenue in Millions : 283
2017 Revenue in Millions : 729
Growth (%) : -61%
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2016 Revenue in Millions : 2,605
2015 Revenue in Millions : 3,134
Growth (%) : -17
LOOKING FOR A SUPPLIER?